Results 31 to 40 of about 556,889 (346)
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Abstract Pancreatic cancer is one of the most serious health issues in developed and developing countries, with a 5‐year overall survival rate currently <9%. Patients typically present with advanced disease due to vague symptoms or lack of screening for early cancer detection.
Xinpeng Yin+6 more
wiley +1 more source
Abstract Background N‐acetyltransferase 10 (NAT10) is the only enzyme known to mediate the N4‐acetylcytidine (ac4C) modification of mRNA and is crucial for mRNA stability and translation efficiency. However, its role in cancer development and prognosis has not yet been explored.
Xiao Zheng+8 more
wiley +1 more source
Novel Mutation in the Feline GAA Gene in a Cat with Glycogen Storage Disease Type II (Pompe Disease)
Glycogen storage disease type II (Pompe disease: PD) is an autosomal recessively inherited fatal genetic disorder that results from the deficiency of a glycogen hydrolyzing enzyme, acid α-glucosidase encoded by the GAA gene.
Tofazzal Md Rakib+8 more
doaj +1 more source
Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment
MCADD is a commonly inherited metabolic disease with serious implications for health outcomes, particularly in children, that may be successfully managed with proper intervention. In this review, we discuss the genetics, pathogenesis, clinical presentation, diagnosis, and treatments for Medium‐Chain Acyl‐CoA Dehydrogenase Deficiency (MCADD ...
Emily Mason+2 more
wiley +1 more source
Neurological Characteristics of Pediatric Glycogen Storage Disease
Glycogen storage diseases (GSD) encompass a group of rare inherited diseases due dysfunction of glycogen metabolism. Hypoglycemia is the most common primary manifestation of GSD, and disturbances in glucose metabolism can cause neurological damage.
Julio Henrique Muzetti+10 more
doaj +1 more source
Hyperammonemia associated with glycogen storage disease type I
M Tunçer, H Yalçin, I Ozalp, M Cağlar
doaj +2 more sources
Introduction: Glycogen storage disease type VI (GSD VI) is a disorder of glycogen metabolism due to mutations in the PYGL gene. Patients with GSD VI usually present with hepatomegaly, recurrent hypoglycemia, and short stature.
Sarah C. Grünert+8 more
doaj +1 more source
A Büchi-Elgot-Trakhtenbrot theorem for automata with MSO graph storage [PDF]
We introduce MSO graph storage types, and call a storage type MSO-expressible if it is isomorphic to some MSO graph storage type. An MSO graph storage type has MSO-definable sets of graphs as storage configurations and as storage transformations. We consider sequential automata with MSO graph storage and associate with each such automaton a string ...
arxiv +1 more source
Liver transplantation for glycogen storage disease types I, III, and IV [PDF]
Glycogen storage disease (GSD) types I, III, and IV can be associated with severe liver disease. The possible development of hepatocellular carcinoma and/or hepatic failure make these GSDs potential candidates for liver transplantation.
Arnaout, W+11 more
core +2 more sources
Abstract Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs < 50 mm compared to HCAs ≥ 50 mm. Changes in final postoperative diagnosis were assessed.
Martijn P. D. Haring+70 more
wiley +1 more source